Business Wire

KONGSBERG Selects Echodyne MESA Radar for Counter-UAS Weapon Systems

9.9.2026 09:00:00 EEST | Business Wire | Press release

Share

Echodyne, the radar platform company, today announced that KONGSBERG has selected Echodyne's MESA® radar platform for a range of air and surface applications. Among the first use cases, KONGSBERG has integrated MESA radar into the PROTECTOR RS4 and PROTECTOR RS6 remote weapon stations (RWS), adding the precision radar data needed to turn the world's most widely deployed RWS family into a highly effective counter-unmanned aircraft system (C-UAS) effector.

The selection pairs KONGSBERG's proven weapon-station architecture and Collaborative Fire Control capabilities with Echodyne's compact, solid-state radar. The result is a scalable approach for adding high-fidelity detection, tracking and targeting data to static, crewed and uncrewed platforms without the size, weight and power demands traditionally associated with high-performance electronically scanned array radar.

"KONGSBERG has set the standard for remote weapon systems through decades of field experience, disciplined engineering and close collaboration with operators," said Eben Frankenberg, CEO of Echodyne. "Integrating MESA radar gives the PROTECTOR family the precise, stable and persistent tracks needed to cue the fire-control system, sustain target lock and act decisively against fast-moving, low-signature drone threats. Just as important, MESA delivers that performance in a compact, software-defined package that can scale across a large installed base and adapt as the threat evolves."

Precision radar data for the fire-control chain

Radar track quality is fundamental to effective fire control. Echodyne's low-SWaP MESA radar supplies high-fidelity range, range-rate, bearing and kinematic data while maintaining the track stability and persistence needed to compute and execute a firing solution. By stabilizing and cueing the optical fire-control system onto a target, the radar helps the weapon station hold lock longer, shorten the detection-to-engagement timeline and improve hit probability against agile, low-radar-cross-section threats.

That precision is particularly important when PROTECTOR systems employ programmable airburst munitions. Accurate range and range-rate measurements support the timing needed to place the munition's effect at the correct point in the target's flight path. In networked operations, a cooperative search radar or another sensor can pass a threat track to the radar-equipped RWS; the local MESA radar then refines and sustains the track for fire-control use. This search-cue-track-engage workflow allows distributed systems to share the air picture, assign targets and rapidly retarget as threats are defeated.

Validated through a multi-year field program

Echodyne and KONGSBERG have spent multiple years integrating, testing and demonstrating the radar-enabled solution in keeping with KONGSBERG's philosophy to prove capability in the field. Beyond the various PROTECTOR integrations, Echodyne and KONGSBERG are exploring additional uses for high-performance radar across air and surface missions within the KONGSBERG portfolio. The companies expect to continue joint technical work focused on resilient sensing, networked fire control and scalable protection against rapidly evolving threats.

Echodyne and KONGSBERG will exhibit at the 34th International Defence Industry Exhibition (MSPO) in Kielce, Poland, September 8-11, 2026

About Echodyne

Echodyne, the radar platform company, is a U.S. innovator and manufacturer of advanced radar solutions for defense, government, and commercial markets. The company’s proprietary MESA architecture is a rare technology breakthrough in advanced radar engineering and design. Echodyne’s innovative MESA technology uses standard materials and manufacturing processes to shatter unit-cost barriers for high-performance radar. The result is a solid-state, low-SWaP, exportable commercial radar with advanced software capabilities that delivers exceptional performance, data integrity, and situational awareness. Echodyne radar systems, including C-UAS and drone radars, are used by systems suppliers, integrators, defense supply chains and end users in more than 40 countries. For more information, visit Echodyne.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260908088002/en/

Contacts

Media contact: David Claxton, media@echodyne.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye